What is LOPJLB’s current signal on PLSE?

LOPJLB’s latest quantitative signal on Pulse Biosciences, Inc. (PLSE) is SELL in a BEAR regime. Signals are updated daily.

What market regime is PLSE in?

Pulse Biosciences, Inc. (PLSE) is currently classified in the BEAR HMM market regime on LOPJLB.

Where is Pulse Biosciences, Inc. based / listed?

Pulse Biosciences, Inc. is based in US, listed on NASDAQ.

Pulse Biosciences, Inc. (PLSE)

COMPARE

Healthcare · Medical - Instruments & Supplies · NASDAQ · US

$49.98+1.81%Close

SELLBEAR · day 8

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONEBEST

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $3.5B
Beta: 1.58
P/E (TTM): -42.52

Short % float: 24.58%
Days to cover: 3.9
SI change: +0.6%

1W: +0.30%
1M: -5.64%

vs SPY 1W: -1.26%
vs SPY 1M: -7.41%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation…

Employees: 116
Headquarters: US
Founded: 2016
Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares out: 69.2M
Float: 18.4%

pulsebiosciences.com ↗

Key executives

Paul Arthur LaViolette — President, Chief Executive Officer & Co-Chairman of the Board

Darrin R. Uecker — Chief Technology Officer & Director

Jon Skinner — Chief Financial Officer

SEC filings

EDGAR · CIK 16251010 · PLSE

Analyst consensus

Buy

Bullish360.0%

Neutral240.0%

Bearish00.0%

L $35.00Avg $53.20H $70.00

Target$53.20+6.44%

Last$49.98

Key stats

Prediction markets

Company news